Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00240032
Status:
COMPLETED
Last Update Posted:
2011-04-11
First Post:
2005-10-13
Brief Title:
A Study to Evaluate the Impact on Skin Injection Site Reactions of Taking an Antihistamine Zyrtec or Placebo Prior to Daily Injections of Copaxone
Sponsor:
Teva Branded Pharmaceutical Products RD Inc
Organization:
Teva Branded Pharmaceutical Products RD Inc
Organization Data
Organization:
Teva Branded Pharmaceutical Products RD Inc
Class:
INDUSTRY
Study ID:
PM014
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Teva Branded Pharmaceutical Products RD Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Thomas Smith MD VP Medical Affairs
Old Organization:
Teva Neuroscience